ANDA 70563, held by USL Pharma. Flurazepam Hydrochloride.
As of Nov 21, 2026, ANDA 70563 (Flurazepam Hydrochloride), held by USL Pharma, was first approved by FDA on Jul 9, 1987, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 9, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Flurazepam Hydrochloride30MG · capsule;oral | Flurazepam Hydrochloride | Discontinued |
| Oct 31, 1990 | Supplement 9Labeling | Approved | None posted |
| Jul 9, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters